Stock doubles on study patients enrollment completion. Oppenheimer will be so excited to hear that they may raise the price target to $500.
Sentiment: Strong Sell
So the 12 month study has just started to enroll, and so meaningful results are at least 12-18 months away....so why would information about enrollment, which was already known.....move the stock....This post is nonsense IMO
O I get it....sarcasm....
hey sport there's 2 LLs in enrollment.. Your spelling the British way.. This is America boy.
Sentiment: Strong Buy
You are correct but try to look it again. The subject is british and the description is american.